Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
for Relapsed/Refractory Multiple Myeloma
Sites in Palo Alto +6 more locations
Sponsor: Ichnos Sciences SA
Sex: All·Age: 18+
Code: NCT05862012·Phase 1·Recruiting·Listed May 2023
Paid Clinical Trials in California
California has 6,346 paid clinical trials enrolling now across cities including Los Angeles, San Francisco and San Diego. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in California include Stanford Medicine, UCLA Health and UCSF, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
5,270 clinical trials
Get a weekly email when new trials open in Los Angeles, CA.
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
for Rheumatoid Arthritis (RA)
Sites in San Francisco, Stanford +8 more locations
Sponsor: Sonoma Biotherapeutics, Inc.
Sex: All·Age: 18 - 71
Code: NCT07123038·Recruiting·Listed Aug 2025
Device Global Registry for the IlluminOss Bone Stabilization System
for Traumatic Fracture
Sites in Los Angeles +9 more locations
Sponsor: IlluminOss Medical, Inc.
Sex: All·Age: 50+
Code: NCT05206981·Recruiting·Listed Jan 2022
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
for Myeloproliferative Neoplasms
Drug: Ruxolitinib
Sites in Palo Alto, Duarte +11 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT06034002·Phase 1·Recruiting·Listed Sep 2023
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
for Cancer
Sites in Los Angeles, Newport Beach +9 more locations
Sponsor: Conjupro Biotherapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05948865·Phase 1·Recruiting·Listed Jul 2023
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
for Chronic Rhinosinusitis Without Nasal Polyps
Sites in Sacramento, Orange +18 more locations
Sponsor: Optinose US Inc.
Sex: All·Age: 12 - 17
Code: NCT06850805·Phase 3·Recruiting·Listed Feb 2025
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
for Ph+ ALL
Sites in Los Angeles, Duarte +14 more locations
Sponsor: Ascentage Pharma Group Inc.
Sex: All·Age: 18+
Code: NCT06051409·Phase 3·Recruiting·Listed Sep 2023
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
for Ulcerative Colitis
Sites in Lancaster, Thousand Oaks +19 more locations
Sponsor: Sanofi
Sex: All·Age: 18 - 75
Code: NCT06975722·Phase 2·Recruiting·Listed May 2025
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
for Hepatocellular Cancer
Sites in Los Angeles, Duarte +8 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06858813·Phase 1·Recruiting·Listed Mar 2025
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
for Acute Hepatic Porphyria
Sites in San Francisco +10 more locations
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 12+
Code: NCT04883905·Recruiting·Listed May 2021
A Global Prospective Observational Registry of Patients With Pompe Disease
for Pompe Disease
Sites in Irvine +14 more locations
Sponsor: Amicus Therapeutics
Sex: All·Age: All ages
Code: NCT06121011·Recruiting·Listed Nov 2023
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
for Hepatocellular Carcinoma
Sites in La Jolla, Beverly Hills +10 more locations
Sponsor: Replimune, Inc.
Sex: All·Age: 18+
Code: NCT05733598·Phase 2·Recruiting·Listed Feb 2023
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for Solid Tumor Malignancies
Sites in Los Angeles +14 more locations
Sponsor: Kumquat Biosciences Inc.
Sex: All·Age: 18+
Code: NCT06994806·Phase 1·Recruiting·Listed May 2025
A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)
for Stress Urinary Incontinence (SUI)
Sites in Los Angeles, San Francisco +11 more locations
Sponsor: UroMems SAS
Sex: Male·Age: 22+
Code: NCT06968741·Recruiting·Listed May 2025
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
for Prostate Cancer
Sites in Anaheim, Santa Rosa +12 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: Male·Age: 18+
Code: NCT04729114·Phase 1·Recruiting·Listed Jan 2021
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
for Heart Failure With Preserved Ejection Fraction (HFpEF
Sites in San Francisco +12 more locations
Sponsor: Axon Therapies, Inc.
Sex: All·Age: 40+
Code: NCT04592445·Recruiting·Listed Oct 2020
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
for Hepatocellular Carcinoma (HCC)
Sites in Orange +12 more locations
Sponsor: RayzeBio, Inc.
Sex: All·Age: 18+
Code: NCT06726161·Phase 1, Phase 2·Recruiting·Listed Dec 2024
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
for Hypoxic-Ischemic Encephalopathy
Sites in San Diego, Orange +12 more locations
Sponsor: ReAlta Life Sciences, Inc.
Sex: All·Age: Up to 10 Hours
Code: NCT05778188·Phase 2·Recruiting·Listed Mar 2023
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
for High-risk Myelodysplastic Syndrome
Sites in Palo Alto, Duarte +9 more locations
Sponsor: Crossbow Therapeutics, Inc.
Sex: All·Age: 12+
Code: NCT06994676·Phase 1·Recruiting·Listed May 2025
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
for Tricuspid Regurgitation
Sites in Los Angeles +9 more locations
Sponsor: VDyne, Inc.
Sex: All·Age: 18+
Code: NCT05848284·Recruiting·Listed May 2023
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
for Locally Advanced Solid Tumor
Sites in Sacramento, Stanford +15 more locations
Sponsor: Nuvalent Inc.
Sex: All·Age: 18+
Code: NCT06521554·Phase 1·Recruiting·Listed Jul 2024
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for Endometrial Cancer
Sites in San Francisco, La Jolla +16 more locations
Sponsor: Faeth Therapeutics
Sex: Female·Age: 18+
Code: NCT06463028·Phase 2·Recruiting·Listed Jun 2024
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
for Relapsed and/or Refractory Multiple Myeloma
Sites in San Francisco, Duarte +11 more locations
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All·Age: 18+
Code: NCT06153251·Phase 1·Recruiting·Listed Dec 2023
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
for Supratentorial Hemorrhage
Sites in Burbank +17 more locations
Sponsor: Integra LifeSciences Corporation
Sex: All·Age: 18+
Code: NCT04494295·Recruiting·Listed Jul 2020
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
for Colorectal Cancer
Drug: NGM120
Sites in Los Angeles, Santa Rosa +10 more locations
Sponsor: NGM Biopharmaceuticals, Inc
Sex: All·Age: 18+
Code: NCT07033026·Phase 2·Recruiting·Listed Jun 2025
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
for Hypogonadism, Male
Sites in Los Angeles, San Francisco +18 more locations
Sponsor: Halozyme Therapeutics
Sex: Male·Age: 12 - 17
Code: NCT06689085·Phase 3·Recruiting·Listed Nov 2024
Suprachoroidal Administration in Subjects With Metastases to the Choroid
for Eye Cancer
Sites in Palo Alto +9 more locations
Sponsor: Aura Biosciences
Sex: All·Age: 18+
Code: NCT06643884·Phase 2·Recruiting·Listed Oct 2024
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
for Carcinoma, Non-Small Cell Lung
Drug: Osimertinib
Sites in Los Angeles +8 more locations
Sponsor: Genprex, Inc.
Sex: All·Age: 18+
Code: NCT04486833·Phase 1, Phase 2·Recruiting·Listed Jul 2020
AMEND TS Early Feasibility Study
for Symptomatic Functional MR 3 or Greater
Sites in La Jolla +10 more locations
Sponsor: Valcare Medical Ltd.
Sex: All·Age: 21+
Code: NCT06951672·Recruiting·Listed Apr 2025
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
for Alpha1-Antitrypsin Deficiency
Sites in Los Angeles, San Francisco +18 more locations
Sponsor: Takeda
Sex: All·Age: 18 - 75
Code: NCT06165341·Phase 3·Recruiting·Listed Dec 2023
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
for Myasthenia Gravis
Sites in San Francisco +16 more locations
Sponsor: argenx
Sex: All·Age: 18+
Code: NCT06298565·Recruiting·Listed Mar 2024
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
for Crohn's Disease
Sites in Lancaster, Escondido +18 more locations
Sponsor: Sanofi
Sex: All·Age: 18 - 75
Code: NCT06958536·Phase 2·Recruiting·Listed May 2025
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
for Acne Scars
Sites in Vista, Redondo Beach +8 more locations
Sponsor: AbbVie
Sex: All·Age: 22+
Code: NCT07207369·Phase 3·Recruiting·Listed Oct 2025
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for Advanced Solid Tumor
Sites in Los Angeles, San Francisco +19 more locations
Sponsor: Clasp Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06778863·Phase 1·Recruiting·Listed Jan 2025
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
for Relapsed or Refractory T Cell Lymphoma
Sites in Palo Alto, Duarte +17 more locations
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All·Age: 18+
Code: NCT05079282·Phase 1·Recruiting·Listed Oct 2021
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
for Renal Cell Carcinoma
Sites in Los Angeles, La Jolla +18 more locations
Sponsor: HiberCell, Inc.
Sex: All·Age: 18+
Code: NCT06234605·Phase 1·Recruiting·Listed Jan 2024
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
for Rett Syndrome
Sites in Los Angeles, San Francisco +12 more locations
Sponsor: Biomed Industries, Inc.
Sex: Female·Age: 5 - 20
Code: NCT06840496·Phase 3·Recruiting·Listed Feb 2025
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
for Chronic Myeloid Leukemia, Chronic Phase
Sites in Orange +17 more locations
Sponsor: Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All·Age: 18+
Code: NCT06163430·Phase 1, Phase 2·Recruiting·Listed Dec 2023
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
for Cachexia
Sites in Newport Beach, Beverly Hills +10 more locations
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT05865535·Phase 1·Recruiting·Listed May 2023
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
for Solid Tumor, Adult
Sites in San Francisco, San Diego +8 more locations
Sponsor: Corbus Pharmaceuticals Inc.
Sex: All·Age: 18+
Code: NCT06265727·Phase 1, Phase 2·Recruiting·Listed Feb 2024